home / stock / slncf / slncf message board
Subject | By | Source | When |
---|---|---|---|
Emylers: SLNCF Financials 07/16/2014 14:39:30 Silence Therapeutics, Plc. Period Ending Total Revenue | Emylers | investorshangout | 07/16/2014 7:39:26 PM |
Silence Therapeutics plc Rating Reiterated by Canaccord Genuity (SLN) | Wildbilly | investorshub | 03/12/2014 5:26:04 PM |
Silence Therapeutics A Quieter Name In RNAi | Wildbilly | investorshub | 03/12/2014 5:18:37 PM |
Stock Tracker: Latest Silence Therapeutics (SLNCF) Headlines Global RNAi Drug Delivery Market 2014-2 | Stock_Tracker | investorshangout | 03/11/2014 1:26:09 PM |
chartguy89: SLNCF 6.30 Stock Charts $SLNCF 1 Month Chart | chartguy89 | investorshangout | 03/10/2014 1:16:26 AM |
chartguy89: SLNCF Stock Charts Last: +0.41 Saturday, March 1, 2014 at 4:17:33 PM $SLNCF 1 Mo | chartguy89 | investorshangout | 03/01/2014 9:17:45 PM |
Silence Therapeutics | gfp927z | investorshub | 06/01/2008 3:08:26 PM |
>>> AtuRNAi | gfp927z | investorshub | 06/01/2008 3:01:24 PM |
Silence Therapeutics | gfp927z | investorshub | 06/01/2008 3:01:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Silence Therapeutics Ord Company Name:
SLNCF Stock Symbol:
OTCMKTS Market:
Silence Therapeutics Ord Website:
Divesiran eliminated the need for phlebotomy in all well-controlled patients following infrequent dosing and was well tolerated Data support advancing divesiran into Phase 2 Company to host conference call today at 8:30am Eastern Time Silence Therapeutics plc (“Si...
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transforming peoples’ lives by silencing diseases through precision engineered medicines, today announced that it will receive a ...
Study demonstrated highly significant and sustained reductions in Lp(a) to week 48 Data support advancing zerlasiran into phase 3 with 300 mg dose Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotec...